Apogee Enterprises
Price & Volume
Stats
See more52W Range | $37.29-$86.42 |
Market Cap | $884.6M |
Shares Short | 546,577 |
Financials
See moreRevenue (12 Mos) | $1.3B |
Revenue Growth (YoY) | 4.6% |
Gross Profit (12 Mos) | $340.3M |
Diluted EPS | $2.35 |
News
See moreYahoo Finance • 7 days ago
Regeneron stock price target raised to $584 from $560 at UBS on Eylea outlook
Yahoo Finance • 8 days ago
Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data
Yahoo Finance • 10 days ago
Bernstein reiterates Outperform rating on Regeneron stock at $750
Yahoo Finance • 10 days ago
Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data
About
CEO | Mr. Ty R. Silberhorn |
CFO | Mr. Matthew J. Osberg |
Address | 4400 West 78th Street, Minneapolis, MN, United States, 55435 |
Sector | Industrials |
Industry | Building Products & Equipment |
Full-Time Employees | 4,500 |
